Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
Titel:
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
Auteur:
Baize, Nathalie Monnet, Isabelle Greillier, Laurent Geier, Margaux Lena, Hervé Janicot, Henri Vergnenegre, Alain Crequit, Jacky Lamy, Regine Auliac, Jean-Bernard Letreut, Jacques Le Caer, Hervé Gervais, Radj Dansin, Eric Madroszyk, Anne Renault, Patrick-Aldo Le Garff, Gwenaëlle Falchero, Lionel Berard, Henri Schott, Roland Saulnier, Patrick Chouaid, Christos